CONTINENTAL ADVISORS LLC - BIOSCRIP INC ownership

BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 101 filers reported holding BIOSCRIP INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CONTINENTAL ADVISORS LLC ownership history of BIOSCRIP INC
ValueSharesWeighting
Q4 2018$617,000
+15.1%
172,8000.0%0.19%
+60.7%
Q3 2018$536,000
+5.9%
172,8000.0%0.12%
-7.1%
Q2 2018$506,000
+19.1%
172,8000.0%0.13%
+16.7%
Q1 2018$425,000
-15.5%
172,8000.0%0.11%
-0.9%
Q4 2017$503,000
-13.4%
172,800
-18.2%
0.11%
-18.0%
Q3 2017$581,000
-1.7%
211,300
-2.9%
0.13%0.0%
Q2 2017$591,000
+59.7%
217,5000.0%0.13%
+60.2%
Q1 2017$370,000
+63.7%
217,5000.0%0.08%
+36.1%
Q4 2016$226,000
-64.1%
217,5000.0%0.06%
-65.3%
Q3 2016$629,000
+13.3%
217,5000.0%0.18%
+2.9%
Q2 2016$555,000
+19.4%
217,5000.0%0.17%
+29.5%
Q1 2016$465,000217,5000.13%
Other shareholders
BIOSCRIP INC shareholders Q1 2016
NameSharesValueWeighting ↓
Venor Capital Management LP 12,005,453$20,409,00010.92%
Coliseum Capital Management, LLC 5,622,410$9,558,0004.30%
Alta Fundamental Advisers LLC 2,217,164$3,769,0004.07%
WYNNEFIELD CAPITAL INC 3,800,000$6,460,0002.37%
ARDSLEY ADVISORY PARTNERS LP 5,280,000$8,976,0001.40%
NORTH TIDE CAPITAL, LLC 3,000,000$5,100,0000.78%
Camber Capital Management LP 10,180,000$17,306,0000.70%
PERKINS CAPITAL MANAGEMENT INC 310,500$528,0000.54%
ROANOKE ASSET MANAGEMENT CORP/ NY 233,280$397,0000.19%
Eidelman Virant Capital 140,000$238,0000.16%
View complete list of BIOSCRIP INC shareholders